During the past decade, University of Utah, Dept. of Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah, Dept. of Neurology" #1 sponsor was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials, followed by "Azevan Pharmaceuticals" with 1 trials sponsored, "OPKO Health, Inc." with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Sunovion" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah, Dept. of Neurology" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "NeuroNEXT Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah, Dept. of Neurology" are "Alzheimer's Disease" (3 trials), "Alzheimer Disease" (1 trials), "Duchenne Muscular Dystrophy" (1 trials), "Epilepsy" (1 trials) and "Huntington's Disease" (1 trials). Many other conditions were trialed in "University of Utah, Dept. of Neurology" in a lesser frequency.

Most popular intervention types in "University of Utah, Dept. of Neurology" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo Control" (3 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo" (2 trials) and "Bapineuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah, Dept. of Neurology" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Utah, Dept. of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Utah, Dept. of Neurology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah, Dept. of Neurology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".